New York, February 23, 2018: The Global Healthcare Biomarkers Market is expected to exceed more than US$ 56 billion by 2022 and will grow at a CAGR of more than 13% in the given forecast period.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche Diagnostics Ltd., Abbott Laboratories, Inc., Agilent Technologies, Inc., Epigenomics AG, GE Healthcare, Johnson & Johnson, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH, Qiagen N.V., and Merck& Co., Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    The scope of the report includes a detailed study of global and regional markets for Global Healthcare Biomarkers Market with the reasons given for variations in the growth of the industry in certain regions.

    Browse Full Report:

    The Global Healthcare Biomarkers Market has been segmented as below:

    By Product Analysis

    •    Consumable
    •    Software
    •    Services

    By Type Analysis

    •    Safety biomarker
    •    Validation biomarker
    •    Efficacy biomarker

    By Application Analysis

    •    Diagnostics development
    •    Personalized medicine
    •    Drug discovery & development
    •    Disease risk assessment

    By Disease indication Analysis

    •    Cancer
    •    Neurological disorders
    •    Cardiovascular disorders
    •    Immunological disorders

    By Regional Analysis

    •    North America
    •    Europe
    •    Asia-Pacific
    •    Rest of the World
    This report provides:

    1) An overview of the global market for Healthcare Biomarkers and related technologies.
    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
    3) Identifications of new market opportunities and targeted promotional plans for Healthcare Biomarkers.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.
    Request Sample Report:

    The major driving factors of Global Healthcare Biomarkers Market are as follows:

    •    Rise in number of cros and low down cost for conduct clinical trials in developing nations.
    •    Use of biomarkers in diagnostic procedure is enhancing rapidly.
    •    Increasing healthcare expenses and R&D funding.

    The restraining factors of Global Healthcare Biomarkers Market are as follows:

    •    Technological issue associated to sample and storage.
    •    High investment and low cost and benefit ratio.
    •    High testing cost

    The Global Healthcare Biomarkers Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.


    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay


    Phone: +1-855-984-1862

    Country: United States